Sex-specific risk factors associated with graves' orbitopathy in Korean patients with newly diagnosed graves' disease

被引:0
|
作者
Lee, Jooyoung [1 ]
Kang, Jinmo [1 ]
Ahn, Hwa Young [2 ]
Lee, Jeong Kyu [3 ]
机构
[1] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea
[2] Chung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[3] Chung Ang Univ, Dept Ophthalmol, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
THYROID-ASSOCIATED OPHTHALMOPATHY; MULTIPLE IMPUTATION; SEVERITY; SMOKING; AGE;
D O I
10.1038/s41433-023-02513-z
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
ObjectiveTo assess sex-specific risk factors for Graves' orbitopathy (GO) in newly diagnosed Graves' disease (GD) patients.MethodsA retrospective cohort study was conducted using the National Health Insurance Service's sample database, which consisted of 1,137,861 subjects from 2002 to 2019. The international classification of disease-10 codes was used to identify those who developed GD (E05) and GO (H062). A multivariable Cox proportional hazards model was used to estimate the effect of risk factors on GO development.ResultsAmong 2145 male and 5047 female GD patients, GO occurred in 134 men (6.2%) and 293 women (5.8%). A multivariable Cox regression model revealed that GO development was significantly associated with younger age (HR = 0.84, 95% CI = 0.73-0.98), low income (HR = 0.55, 95% CI = 0.35-0.86), and heavy drinking (HR = 1.79, 95% CI = 1.10-2.90) in men, and with younger age (HR = 0.89, 95% CI = 0.81-0.98), lower body mass index (HR = 0.55, 95% CI = 0.33-0.90), high total cholesterol (HR = 1.04, 95% CI = 1.01-1.06), hyperlipidaemia (HR = 1.37, 95% CI = 1.02-1.85), and lower statin dose (HR = 0.37, 95% CI = 0.22-0.62) in women. There was no association between smoking and GO development in both men and women.ConclusionsThe risk factors for GO development were sex-dependent. These results show the need for more sophisticated attention and support considering sex characteristics in GO surveillance.
引用
收藏
页码:3382 / 3391
页数:10
相关论文
共 50 条
  • [21] Comparative assessment of gut microbial composition and function in patients with Graves’ disease and Graves’ orbitopathy
    T.-T. Shi
    Z. Xin
    L. Hua
    H. Wang
    R.-X. Zhao
    Y.-L. Yang
    R.-R. Xie
    H.-Y. Liu
    J.-K. Yang
    Journal of Endocrinological Investigation, 2021, 44 : 297 - 310
  • [22] Endothelial dysfunction in children with newly diagnosed Graves' disease
    Gamal, Yasser
    Badawy, Ahlam
    Ali, Ahmed M.
    Farghaly, Hekma Saad
    Metwalley, Kotb Abbass
    Gaber, Noha
    Allam, Momtaz Thabet
    Farouk, Yasser
    EUROPEAN JOURNAL OF PEDIATRICS, 2023, 182 (06) : 2793 - 2800
  • [23] Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy
    Shi, T-T
    Xin, Z.
    Hua, L.
    Wang, H.
    Zhao, R-X
    Yang, Y-L
    Xie, R-R
    Liu, H. Y.
    Yang, J-K
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (02) : 297 - 310
  • [24] Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy
    Bartalena, Luigi
    Piantanida, Eliana
    Gallo, Daniela
    Lai, Adriana
    Tanda, Maria Laura
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [25] High rates of fatigue in newly diagnosed Graves' disease
    Moller, Marika C.
    Bartfai, Aniko
    de Boussard, Catharina Nygren
    Radestad, Angelique Floter
    Calissendorff, Jan
    FATIGUE-BIOMEDICINE HEALTH AND BEHAVIOR, 2014, 2 (03): : 153 - 162
  • [26] High Titers of Thyrotropin Receptor Antibodies Are Associated With Orbitopathy in Patients With Graves Disease
    Kahaly, George J.
    Wuster, Christian
    Olivo, Paul D.
    Diana, Tanja
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (07): : 2561 - 2568
  • [27] Risk factors for Graves' disease
    Slavenka M. Janković
    Vladan R. Radosavlijević
    Jelena M. Marinković
    European Journal of Epidemiology, 1997, 13 : 15 - 18
  • [28] Risk factors for Graves' disease
    Jankovic, SM
    Radosavljevic, VR
    Marinkovic, JM
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1997, 13 (01) : 15 - 18
  • [29] Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease
    Suzuki, Nami
    Noh, Jaeduk Yoshimura
    Sugisawa, Chiho
    Hoshiyama, Ayako
    Hiruma, Marino
    Kawaguchi, Akiko
    Morisaki, Mitsuha
    Ohye, Hidemi
    Suzuki, Miho
    Matsumoto, Masako
    Kunii, Yo
    Yoshihara, Ai
    Watanabe, Natsuko
    Sugino, Kiminori
    Ito, Kochi
    ENDOCRINE JOURNAL, 2020, 67 (06) : 631 - 638
  • [30] Identifying and Validating Differentially Methylated Regions in Newly Diagnosed Patients with Graves' Disease
    Cai, Tiantian
    Qin, Qiu
    Song, Ronghua
    Zhao, Jing
    Wang, Guofei
    Zhang, Jinan
    DNA AND CELL BIOLOGY, 2021, 40 (03) : 482 - 490